Q3 Innovations DrugHAWK ECO Cup User Manual

Page 5

Advertising
background image

Tetracycline

Tetrahydrocortisone 3-acetate

Tetrahydrocortisone 3 (b-D-glucuronide)

Tetrahydrozoline

Thiamine

Thioridazine

D/L-Tyrosine

Tolbutamide

Triamterene

Trifluoperazine

Trimethoprim

Tryptamine

D/L-Tryptophan

Tyramine

Uric acid

Verapamil

Zomepirac

O-Hydroxyhippuric acid

p-Hydroxyamphetamine

p-Hydroxytyramine

Ibuprofen

Iproniazid

D/L-Isoproterenol

Isoxsuprine

Ketamine

Ketoprofen

Labetalol

Loperamide

Meperidine

Meprobamate

Methoxyphenamine

Methylphenidate

Nalidixic acid

Naloxone

Naltrexone

Naproxen

Niacinamide

Nifedipine

Norethindrone

D-Norpropoxyphene

Noscapine

D/L-Octopamine

Oxalic acid

Oxolinic acid

Oxymetazoline

Papaverine

Penicillin-G

Pentazocine hydrochloride

Perphenazine

Phenelzine

Trans-2-phenylcyclo-propylamine hydrochloride

L-Phenylephrine

ß-Phenylethylamine

Phenylpropanolamine

Prednisolone

Prednisone

D/L-Propranolol

D-Propoxyphene

D-Pseudoephedrine

Quinacrine

Quinine

Quindine

Ranitidine

Salicylic acid

Serotonin

Sulfamethazine

Sulindac

Acetaminophen

Acetophenetidin

N-Acetylprocainamide

Acetylsalicylic acid

Aminopyrine

Amoxicillin

Ampicillin

L-Ascorbic acid

Apomorphine

Aspartame

Atropine

Benzilic acid

Benzoic acid

Benzphetamine*

Bilirubin

D/L-Brompheniramine

Caffeine

Cannabidol

Chloralhydrate

Chloramphenicol

Chlorothiazide

D/L-Chloropheniramine

Chlorpromazine

Chloroquine

Cholesterol

Clonidine

Cortisone

L-Cotinine

Creatinine

Deoxycorticosterone

Dextromethorphan

Diclofenac

Diflunisal

Digoxin

Diphenhydramine

Ecgonine methyl ester

L -Ψ-Ephedrine

b-Estradiol

Estrone-3-sulfate

Ethyl-p-aminobenzoate

[1R,2S] (-) Ephedrine

L(–)-Epinephrine

Erythromycin

Fenoprofen

Furosemide

Gentisic acid

Hemoglobin

Hydralazine

Hydrochlorothiazide

Hydrocortisone

Effect of Urinary Specific Gravity

Fifteen (15) urine samples of normal, high, and low specific gravity ranges (1.005, 1.015, 1.03) were

spiked with drugs at 50% below and 50% above cut-off levels respectively. The

ECO CUP™ One

Step Drug Test

was tested in duplicate using ten drug-free urine and spiked urine samples. The

results demonstrate that varying ranges of urinary specific gravity do not affect the test results.

Effect of the Urinary pH

The pH of an aliquoted negative urine pool was adjusted to pH ranges of 4.0 ,4.5, 5.0, 6.0 and 9.0,and

spiked with drugs at 50% below and 50% above cut-off levels. The spiked, pH-adjusted urine was

tested with the

ECO CUP™ One Step Drug Test

. The results demonstrate that varying ranges of

pH do not interfere with the performance of the test.

Cross-Reactivity

A study was conducted to determine the cross-reactivity of the test with compounds in either drug-free

urine or drug positive urine containing Cocaine, Barbiturates, Benzodiazepines, Amphetamine,

Methamphetamine, Marijuana, Methadone, MDMA (Ecstasy), Opiates, Oxycodone, Phencyclidine or

Tricyclic Antidepressants. The following compounds show no cross-reactivity when tested with The

ECO CUP™ One Step Drug Test

at concentrations of 100.µg/mL.

Non Cross-Reacting Compounds

*Parent compound only; metabolizes into amphetamine and methamphetamine in the body.

BIBLIOGRAPHY

1. Stewart DJ, Inaba T, Lucassen M, Kalow W. Clin. Pharmacol. Ther. April 1979; 25 ed: 464, 264-8.

2. Ambre J. J. Anal. Toxicol. 1985; 9:241.

3. Hawks RL, CN Chiang. Urine Testing for Drugs of Abuse. National Institute for Drug Abuse (NIDA), Research

Monograph 73, 1986.

4. Tietz NW. Textbook of Clinical Chemistry. W.B. Saunders Company. 1986; 1735.

5. FDA Guidance Document: Guidance for Premarket Submission for Kits for Screening Drugs of Abuse to be Used

by the Consumer, 1997.

6. Robert DeCresce. Drug Testing in the workplace, 114.

7. Baselt RC. Disposition of Toxic Drugs and Chemicals in Man. 2nd Ed. Biomedical Publ., Davis, CA 1982; 487.

8. OSHA, The Bloodborne Pathogens Standard 29, Code of Federal Regulations 29 CFR 1910.1030.

9. CDC, Centers for Disease Control (CDC) Guidelines, Morbidity and Mortality Weekly Report, Volume 37, Number

24, 1988.

Distributed by:

Effective Date: 20090320

PN:
Y031

11

11901

Advertising